📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Robust antibody responses in 70-80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021. (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2807/1560-7917.es.2021.26.12.2100329

PubMed Identifier: 33769252

Publication URI: http://europepmc.org/abstract/MED/33769252

Type: Journal Article/Review

Volume: 26

Parent Publication: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Issue: 12

ISSN: 1025-496X